The journey from identifying a potential new medicine to bringing it to patients is notoriously long, breathtakingly expensive, and fraught with high failure rates. Traditional drug discovery, while achieving monumental successes, is often a slow, painstaking process. However, a new era is dawning, driven by the convergence of advanced laboratory automation, robotics, and artificial intelligence. […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.